Plasma homocysteine, methylene tetrahydrofolate reductase C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion.

Abstract

AIMS To determine whether plasma homocysteine, methylene tetrahydrofolate reductase (MTHFR) C677T and factor II G20210A polymorphisms, factor VIII, and vWF are risk factors for central retinal vein occlusion (CRVO). METHOD Prospective comparison of 63 consecutive patients with central retinal vein occlusion and 63 age matched controls. Plasma homocysteine… (More)

Topics

2 Figures and Tables

Cite this paper

@article{Boyd2001PlasmaHM, title={Plasma homocysteine, methylene tetrahydrofolate reductase C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion.}, author={S. Boyd and D. Jason Owens and Thomas J. Gin and Kimberly D. Bunce and Hooman Sherafat and D. Perry and Philip G Hykin}, journal={The British journal of ophthalmology}, year={2001}, volume={85 11}, pages={1313-5} }